Navigation Links
The 'Anatomy' of Clinical Trials: 'Grey's' Season Finale Leaves Public in the Dark About the Myths and Realities
Date:5/22/2008

Coalition of Cancer Cooperative Groups sheds light on the fact that cancer clinical trials like those on Grey's Anatomy are not just 'do or die.'

PHILADELPHIA, May 22 /PRNewswire/ -- With the past several episodes and two-hour season finale of "Grey's Anatomy" centered on the emotional sagas of cancer clinical trial patients and their doctors, the subject tops the list of the country's healthcare "hot topics." While "Grey's" has done a service in making the public aware that cancer clinical trial options exist, the concern is that the drama which makes for a compelling prime-time show doesn't allow for an accurate, nor complete, portrayal of the role clinical trials play in guaranteeing continued progress in the fight against cancer.

The season finale this Thursday will only contribute to the negative perception being portrayed on the show that cancer "clinical trials" usually equal a "death sentence."

"Cancer clinical trials are highly-structured and follow a well-defined protocol with careful supervision," said Robert L. Comis, MD, President and Chairman of the Coalition of Cancer Cooperative Groups. "Trials can provide patients at all stages of cancer with the most cutting-edge medical treatment, the highest level of care and the possibility of more effective therapy than if they went the standard course. A clinical trial is a treatment option to be considered at the point of diagnosis-not only a last-ditch effort when all other options are exhausted."

A clinical trial is a carefully monitored medical research study in which people participate to test new methods of prevention, screening, diagnosis, or treatment of a disease. The majority of patients who participate in cancer clinical trials do so in phase III studies, which are designed to evaluate whether a new treatment or procedure is more effective than the current standard of care.

The knowledge gained through cancer clinical trial research has helped scientists and doctors develop new ways to slow, halt, cure and prevent cancer. However, of the 1.3 million people who will be diagnosed with cancer this year, only 3 to 5 percent of adults will participate in cancer clinical trials.

The Coalition of Cancer Cooperative Groups is a nonprofit organization with a goal to improve the quality of life and survival of cancer patients by increasing participation in cancer clinical trials as treatment options-not last-hope efforts. As a non-profit, the Coalition offers the added benefit of providing non-biased cancer clinical trial information.

At the core of the Coalition's service is their online TrialCheck(R), the nation's premier free cancer clinical trials navigation and matching service offering the most up-to-date source of cancer clinical trial information. Used by organizations such as American Cancer Society, American Society of Clinical Oncology, the state of Georgia, and soon The Leukemia & Lymphoma Society, the award-winning TrialCheck is accessible to more than 3 million patients and caregivers each month.

"Clinical research has led to almost all cancer treatments used today," said Comis. "Because of the knowledge gained through clinical trials, approximately two-thirds of cancer patients survive at least five years after diagnosis, compared with only fifty percent in the 1970s. We need to keep reinforcing this fact and encouraging patients and their physicians to look at all the options when facing a cancer diagnosis."

Advances identified through clinical trials include: Cancer screening techniques, such as mammograms; adjuvant chemotherapy (chemo after surgery); therapies targeting genetic and molecular defects that make a cell cancerous; Cancer vaccines and "chemoprevention" drugs; profiling of cancer genes; and new insights into the long-term health of cancer survivors, who are at greater risk of heart problems, second cancers and other health issues.

Certainly, misperceptions about the negativity of clinical trials for treating cancer patients existed before Grey's, but the episodes have heightened the dynamic, making now the crucial time to set the record straight ... to debunk the myths and reinforce the fact that only patient participation in clinical trials will guarantee continued progress in the fight against cancer.

"Cancer clinical trial patients do not need to fear the possibility of not receiving treatment ... placebos are never given in place of treatment when an existing standard therapy exists," said Comis. "Our goal right now is to provide the public with the knowledge that helps them distinguish entertainment fiction from the reality of cancer clinical trial benefits."

About the Coalition of Cancer Cooperative Groups

The Coalition of Cancer Cooperative Groups is the nation's only nonprofit organization of its kind, devoted solely to the improvement of patient access to cancer clinical trials. Comprised of members from the 10 National Cancer Institute-sponsored Cooperative Groups, dozens of patient advocacy organizations and 8,000 oncology and cancer research specialists, the Coalition is helping to increase awareness of cancer clinical trials as a treatment option through information and services at http://www.CancerTrialsHelp.org .


'/>"/>
SOURCE The Coalition of Cancer Cooperative Groups
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
2. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
3. Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
4. ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
5. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
6. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
7. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
8. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
9. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
10. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
11. Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... VEGAS , June 26, 2016 ... to value-based care operating models within the health care ... enable greater financial efficiency , Deloitte offers a ... the key business issues impacting efficient cost optimization: labor ... , These services facilitate better outcomes and better ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):